CIK 0001534969 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261911522
- Phone
- (801) 990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Open-market sale Chief Medical Officer sold 362 shares at $2.01 ($728)
- 4 Open-market sale General Counsel sold 2,179 shares at $2.01 ($4,380)
- 4 Open-market sale Chief Executive Officer sold 20,755 shares at $2.08 ($43,170)
- 4 Open-market sale Chief Financial Officer sold 5,440 shares at $2.08 ($11,315)
- 4 Planned sale Director sold 1,560 shares at $2.15 ($3,354)
- 4 Insider Changes in Ownership
- 4 Grant or award General Counsel acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 3,168 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Grant or award Chief Executive Officer acquired 154,440 shares (grant or award)
- 4 Grant or award General Counsel acquired 44,215 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 17,437 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 12,455 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 44,215 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 25,612 shares at an average $1.92 ($49,079)
- 4 Open-market sale Chief Data Officer sold 1,396 shares at $2.04 ($2,848)
- 4 Open-market sale General Counsel sold 1,027 shares at $2.04 ($2,095)
- 4 Open-market sale Chief Information Officer sold 716 shares at $2.04 ($1,461)
Page 2 of 16 · 313 filings